Literature DB >> 1531330

Nucleocytoplasmic transport: the influenza virus NS1 protein regulates the transport of spliced NS2 mRNA and its precursor NS1 mRNA.

F V Alonso-Caplen1, M E Nemeroff, Y Qiu, R M Krug.   

Abstract

Influenza virus unspliced NS1 mRNA, like retroviral pre-mRNAs, is efficiently exported from the nucleus and translated in the cytoplasm of infected cells. With human immunodeficiency virus (HIV), the transport of viral pre-mRNAs is facilitated by the viral Rev protein. We tested the possibility that the influenza virus NS1 protein, a nuclear protein that is encoded by unspliced NS1 mRNA, has the same function as the HIV Rev protein. Surprisingly, using transient transfection assays, we found that rather than facilitating the nucleocytoplasmic transport of unspliced NS1 mRNA, the NS1 protein inhibited the transport of NS2 mRNA, the spliced mRNA generated from NS1 mRNA. The efficient transport of NS2 mRNA from the nucleus to the cytoplasm occurred only when the synthesis of the NS1 protein was abrogated by amber mutations. The NS1 protein down-regulated the export of NS2 mRNA whether or not it was generated by splicing, indicating that the NS1 protein acted directly on transport. Actinomycin D chase experiments verified that the NS1 protein acted on the transport and not on the differential stability of NS2 mRNA in the nucleus as compared to the cytoplasm. In addition, the NS1 protein inhibited the transport of NS1 mRNA itself, which contains all of the sequences in NS2 mRNA, particularly when NS1 mRNA was released from the splicing machinery by mutating its 3'-splice site. Our results indicate that the NS1 protein-mediated inhibition of transport requires sequences in NS2 mRNA. The transport of the viral PB1 protein, nucleocapsid protein, hemagglutinin, membrane protein, and M2 mRNAs was not affected by the NS1 protein. When the NS2 mRNA sequence was covalently attached to the PB1 mRNA, the transport of the chimeric mRNA was inhibited by the NS1 protein. Our results identify a novel function of the influenza virus NS1 protein and demonstrate that post-transcriptional control of gene expression can also occur at the level of the nucleocytoplasmic transport of a mature, spliced mRNA.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1531330     DOI: 10.1101/gad.6.2.255

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  31 in total

1.  Polyuridylated mRNA synthesized by a recombinant influenza virus is defective in nuclear export.

Authors:  L L Poon; E Fodor; G G Brownlee
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 2.  Cytopathogenesis and inhibition of host gene expression by RNA viruses.

Authors:  D S Lyles
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

3.  Selective translation of eukaryotic mRNAs: functional molecular analysis of GRSF-1, a positive regulator of influenza virus protein synthesis.

Authors:  John C Kash; Dawn M Cunningham; Maria W Smit; Youngwoo Park; David Fritz; Jeffrey Wilusz; Michael G Katze
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

4.  Deletion derivatives of the MuDR regulatory transposon of maize encode antisense transcripts but are not dominant-negative regulators of mutator activities.

Authors:  Soo-Hwan Kim; Virginia Walbot
Journal:  Plant Cell       Date:  2003-09-24       Impact factor: 11.277

5.  Implication of a cis-acting element in the cytoplasmic accumulation of unspliced Borna disease virus RNAs.

Authors:  P A Schneider; M Schwemmle; W I Lipkin
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

6.  Mutations at alternative 5' splice sites of M1 mRNA negatively affect influenza A virus viability and growth rate.

Authors:  Chiayn Chiang; Guang-Wu Chen; Shin-Ru Shih
Journal:  J Virol       Date:  2008-09-03       Impact factor: 5.103

7.  The choice of alternative 5' splice sites in influenza virus M1 mRNA is regulated by the viral polymerase complex.

Authors:  S R Shih; M E Nemeroff; R M Krug
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-03       Impact factor: 11.205

8.  New approach for inhibiting Rev function and HIV-1 production using the influenza virus NS1 protein.

Authors:  X Y Qian; Z Y Chen; J Zhang; A B Rabson; R M Krug
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-20       Impact factor: 11.205

9.  U6atac snRNA, the highly divergent counterpart of U6 snRNA, is the specific target that mediates inhibition of AT-AC splicing by the influenza virus NS1 protein.

Authors:  W Wang; R M Krug
Journal:  RNA       Date:  1998-01       Impact factor: 4.942

10.  Novel exploitation of a nuclear function by influenza virus: the cellular SF2/ASF splicing factor controls the amount of the essential viral M2 ion channel protein in infected cells.

Authors:  S R Shih; R M Krug
Journal:  EMBO J       Date:  1996-10-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.